Cavanaugh Sarah

Average Profitability
275.1%
Insider Buys Quantity
1
Insider Buys Sum
$5,071.50
Insider Sells Quantity
4
Insider Sells Sum
$1.36M

Insider Activity of Cavanaugh Sarah

According to the SEC Form 4 filings, Cavanaugh Sarah, being in a position of

  1. SVP OF CORP AFFAIRS & ADMIN. at Celldex Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 20853 shares for $703,334,
    over all time since 2020-06-10, has bought 1050 shares for $5,072, and sold 36854 shares for $1.36M.

The largest purchase of all time was on 2020-06-10 and amounted to 1050 shares of Celldex Therapeutics, Inc. for $5,072.

The largest sale of all time was on 2024-05-30 and amounted to 20853 shares of Celldex Therapeutics, Inc. for $703,334.

Biography of Cavanaugh Sarah

No biography is available at this moment.

2024-05-30SaleCelldex Therapeutics, Inc.
CLDX
SVP OF CORP AFFAIRS & ADMIN.
20,853
0.0317%
$33.73$703,334+4.94%
2022-08-17SaleCelldex Therapeutics, Inc.
CLDX
SVP OF CORP AFFAIRS & ADMIN.
1,355
0.0029%
$36.38$49,289-4.68%
2021-12-08SaleCelldex Therapeutics, Inc.
CLDX
SVP of Corp Affairs & Admin.
7,323
0.0158%
$40.00$292,920-20.89%
2021-11-01SaleCelldex Therapeutics, Inc.
CLDX
SVP of Corp Affairs & Admin.
7,323
0.0154%
$43.26$316,804-28.71%
2020-06-10PurchaseCelldex Therapeutics, Inc.
CLDX
SVP of Corp Affairs & Admin.
1,050
0.0048%
$4.83$5,072+275.1%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.